Old Web
English
Sign In
Acemap
>
Paper
>
Reboxetine augmentation of fluoxetine for patients with major depressive disorder: An 8-week open-label study
Reboxetine augmentation of fluoxetine for patients with major depressive disorder: An 8-week open-label study
2002
M. Rapaport
C. Wilcox
J. Heiser
P. Londborg
G. Schwartz
Keywords:
Clinical psychology
Psychology
Psychiatry
Endogenous depression
Major depressive disorder
Reboxetine
Fluoxetine
open label study
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]